Calendrier des promotions Astellas Pharma Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Astellas Pharma Inc.
Astellas Pharma Inc. производит, продает, импортирует и экспортирует фармацевтическую продукцию по всему миру. plus de détailsParamètres de base
ISIN
US04623U1025
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
jpy
Див.доход ао
4.14
Дивиденд ао
0.4709
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 1.82 | 8 |
| P/BV | 1.83 | 8 |
| P/E | 171.67 | 1 |
Efficacité
| Nom | Signification | Grade |
| ROA | 0.5657 | 1 |
| ROE | 1.1 | 1 |
| ROIC | 13.08 | 4 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 4.14 | 10 |
| DSI | 0.8571 | 8.57 |
| Croissance moyenne du dividende | 5.73 | 9.56 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 4.72 | 1 |
| Debt/Ratio | 0.2577 | 10 |
| Debt/Equity | 1.24 | 8 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 23.28 | 4 |
| Rentabilité Ebitda, % | -43.67 | 0 |
| Rentabilité EPS, % | -90.91 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 9.69 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 9.43 $ | 0 $ | 0 $ | 2.76 % | 0 % | 0 % |
| common.calendar.number_days.30d | 9.57 $ | 9.12 $ | 9.69 $ | 1.25 % | 0 % | 0 % |
| common.calendar.number_days.90d | 9.73 $ | 8.86 $ | 10.15 $ | -0.41 % | 0 % | 0 % |
| common.calendar.number_days.180d | 10.17 $ | 8.86 $ | 10.15 $ | -4.72 % | 0 % | 0 % |
| common.calendar.number_days.1y | 9.99 $ | 8.86 $ | 12.64 $ | -3 % | 0 % | 0 % |
| common.calendar.number_days.3y | 15.56 $ | 8.86 $ | 16.79 $ | -37.72 % | 0 % | 0 % |
| common.calendar.number_days.5y | 16.79 $ | 8.86 $ | 18.17 $ | -42.29 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 8.86 $ | 18.17 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 9.9 $ | 8.86 $ | 10.15 $ | -2.13 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
| ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
FINEX JAPAN UCITS ETF
|
29 | 155.8 | 0.9 |
| 29 | 155,8 | 0,9 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Ms. Catherine B. Levitt | General Counsel | N/A | |
| Mr. Stig Ogata | Vice President of Corporate Communications | N/A | |
| Mr. Naoki Okamura BSc | President, CEO & Director | 963.45k | 1962 (63 année) |
| Mr. Yoshitsugu Shitaka Ph.D. | Chief Scientific Officer & Senior Managing Executive Officer | N/A | |
| Nobue Yasuda | General Manager of Finance & Accounting Department | N/A | |
| Mr. Katsuyoshi Sugita | Chief People Officer, Chief Ethics & Compliance Officer, EVP of HR and Representative Director | N/A | 1967 (58 années) |
| Ms. Tatjana Dragovic | Senior VP and Head of Ethics & Compliance | N/A | |
| Mr. Nobuaki Tanaka | President of Japan Commercial & Senior Corporate Executive | N/A | |
| Mr. Atsushi Kitamura | Senior Executive Officer & CFO | N/A | |
| Jun Kono | Senior Executive Officer & Head of Japan Commercial |
Informations sur l'entreprise
Adresse: Japan, Tokyo, 2-5-1 Nihonbashi-Honcho - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.astellas.com
Site web: https://www.astellas.com
